Innovative Stem Cell Therapeutic Strategy May be Transformative for Heart Failure Treatment
MedStar Heart in partnership with CardioCell has been approved to conduct an investigational new drug clinical trial, called STEMVAD at MedStar Heart & Vascular Institute. The goal of this study is to determine whether stem cell therapy improves myocardial function in patients with severe heart failure. “Innovative therapies to improve heart function and outcomes of patients with advanced heart failure are sorely needed,” said Selma Mohammed, MD, PhD.
MedStar Health to Initiate a Feasibility Trial on Burn Wounds Treated with Kerecis Omega3
Researchers from MedStar Washington Hospital Center and MedStar Health Research Institute will begin an Investigational Device Exemption (IDE) trial on full-thickness burn wounds using Kerecis Omega3 Burn. The feasibility trial seeks to gather data to obtain FDA approval for a full clinical trial, which can lead to indications as a treatment for third-degree burn wounds.
MedStar Health Awarded HHS ONC Funding to Advance Health IT AND Clinical Knowledge at Point of Care
MedStar Health’s National Center for Human Factors in Healthcare is one of two winners nationally to be awarded nearly $2 million of combined funding over two years to accelerate health IT interoperability. Part of the Leading Edge Acceleration Projects in Health IT grant, the work will transform stand-alone Million Hearts risk calculators for heart disease, stroke, and cardiovascular disease into tools for clinicians.
Medicaid Expansion under the Affordable Care Act Did Not Increase Access to Complex Surgeries for Low Income Patients
Researchers from MedStar-Georgetown Surgical Outcomes Research Center, under senior investigator, Waddah B. Al-Refaie, MD, FACS, found that the Affordable Care Act Medicaid expansion did not increase use of complex surgical procedures at high volume hospitals for low-income/minority patients. Al- Refaie and his collaborators have proposed a number of concerns that may have an effect on vulnerable populations being able to benefit from complex surgical care at high volume hospitals.